Cellics Therapeutics

Cellics Therapeutics, Inc. is a biotechnology company focused on developing novel cell-mimicking nanotechnology platforms to address a range of serious diseases, including infectious and inflammatory conditions. The company’s core technology, called cell membrane-coated nanoparticles, is designed to neutralize toxins and pathogens by mimicking the body’s own cells, which enables targeted therapeutic delivery and immune modulation. Cellics generates revenue primarily through research partnerships, licensing agreements, and potential future commercialization of its proprietary therapeutics. Founded in 2014 and headquartered in San Diego, Cellics has attracted attention for its innovative approach and collaborations with leading academic institutions. Candidates should be aware of the company’s emphasis on scientific innovation and its mission to transform treatment paradigms in medicine.

Recent Posts by Cellics Therapeutics

1-1 of 1